Check our guide to legitimate GLP-1 treatment programs to compare what you actually get for your money
Griffin SJ, Leaver JK, Irving GJ (2017) Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
GLP-1s May Prevent Rheumatic Disease From Developing A Harvard-led propensity-matched cohort study, also presented at ACR Convergence 2025 by Dr
SeekPeptides members access comprehensive tracking tools, protocol databases, and community insights that help optimize GLP-1 treatment from the first dose through long-term maintenance
Health plans dont consider them a medical treatment, unlike FDA-approved drugs that have regulatory backing for coverage
In five studies, background glucose-lowering treatment comprised metformin either as monotherapy or in combination with another oral medication